Home >Companies >Company-results >Ranbaxy Q3 net loss widens to Rs1,030 crore on forex woes

Mumbai: Ranbaxy Laboratories Ltd on Wednesday said its loss widened to 1,029.73 crore for the December quarter from 158.94 crore in the same period a year ago.

Net sales for the quarter fell 9.51% from a year-ago to 2,618.85 crore from 2,893.99 crore.

Tax expenses for the quarter rose 805% to 888.19 crore from 85.14 crore a year ago.

“Ranbaxy recorded good growth in India, Russia, APAC (Asia Pacific) and LATAM (Latin America) during the quarter. However, overall sales were impacted by global currency depreciation in some markets", Arun Sawhney chief executive and managing director said.

At 3.04pm, Ranbaxy Laboratories shares fell 1.5% to 696.35 on the BSE, while the exchange’s benchmark Sensex shed 0.16% to 29524.38 points.

Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.

Never miss a story! Stay connected and informed with Mint. Download our App Now!!

Edit Profile
My ReadsRedeem a Gift CardLogout